Ads
related to: new cancer drug keytruda- How Does KEYTRUDA Work?
Learn About KEYTRUDA and How
It May Help Eligible Patients.
- Treatment With KEYTRUDA
Learn More About Treatment
With KEYTRUDA Here.
- Clinical Trial Results
Get Information About Clinical
Trial Results for KEYTRUDA.
- Resources and FAQ
Find Patient Information, FAQs,
and Additional Resources Here.
- How Does KEYTRUDA Work?
Search results
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 19 hours agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the ...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 23 hours agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 1 day agoKeytruda made up more than 40% of Merck...sales and help the company diversify beyond Keytruda. The...
Roche’s Sabry retires; Duchenne drug fails confirmatory test
BioPharma Dive via Yahoo Finance· 2 days agoThe veteran executive will be replaced by Boris Zaïtra. Elsewhere, Nippon Shinyaku shared negative...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 4 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe Phase..., a research group leader at the Netherlands Cancer Institute, said: “These findings are...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 7 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Hedge Funds Are Loading Up On This Dividend Stock
Benzinga via Yahoo Finance· 3 days agoThe markets are adjusting to the high interest rates environment, with all the major US stock indices reporting strong gains in May 2024. However, even...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
WPRI Providence· 6 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment ...
TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders
Morningstar· 3 days agoTME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment ...
Ads
related to: new cancer drug keytruda
